NewsRx

Search our medical news database

Australian Cancer Technology, Ltd.

Australian biotech company changes name

Published in Disease Risk Factor Week, July 3rd, 2005

Australian Cancer Technology, Ltd., (ASX:ACU) announced that the company's name has changed to Avantogen Limited, by a vote of shareholders at a general meeting in Sydney on May 9, 2005.

Avantogen will continue to be traded on the Australian Stock Exchange (ASX) under the symbol ACU. The company has established a Level 1 ADR stock program in the U.S., trading under the symbol AUCJY, and also is listed under the symbol CBS on the Xetra exchange, the electronic trading system of the Frankfurt Stock Exchange. Both of these foreign exchange symbols will also stay the same for the present.

"This name change symbolizes the beginning of a new, exciting era...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Disease Risk Factor Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook